OS Therapies Inc
OS Therapies Inc
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Convertible Notes A Net Debt Discount | - | - | - | - | - | - | - | - | 0 | 1 | |||||
Assets | |||||||||||||||
Related Party | - | - | - | - | - | 0 | - | - | - | - | |||||
Cash And Cash Equivalents At Carrying Value | - | 1 | - | 2 | - | 3 | - | 2 | - | - | |||||
Assets Current | |||||||||||||||
Convertible Notes A Related Party Net Debt Discoun… | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Convertible Notes B Net Debt Discount | - | - | - | - | - | - | - | - | 0 | 5 | |||||
Convertible Notes C Net Debt Discount | - | - | - | - | - | - | - | - | 0 | 4 | |||||
Cash | 0 | 1 | 0 | - | 3 | 3 | 6 | 2 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | - | - | 0 | 0 | 1 | 1 | - | - | - | - | |||||
Prepaid Expense Current | 0 | - | - | - | - | - | - | 0 | - | - | |||||
Other Receivables | - | - | - | - | - | - | - | 0 | 0 | - | |||||
Assets Current | 4 | 1 | 0 | 2 | 4 | 4 | 6 | 2 | 1 | 1 | |||||
Long Term Assets | |||||||||||||||
Assets Noncurrent | |||||||||||||||
Convertible Notes D Net Debt Discount | - | - | - | - | - | - | - | - | 0 | 2 | |||||
Convertible Notes E Net Debt Discount | - | - | - | - | - | - | - | - | 0 | 1 | |||||
Convertible Notes F Net Debt Discount | - | - | - | - | - | - | - | - | 1 | 2 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets | |||||||||||||||
Deferred Offering Costs | - | - | - | - | - | - | - | - | - | 1 | |||||
Deposits Assets Noncurrent | 6 | 6 | 7 | 7 | 7 | 0 | - | - | - | - | |||||
Assets Noncurrent | 6 | 6 | 7 | - | - | - | 0 | - | - | - | |||||
Assets | 10 | 7 | 7 | 9 | 10 | 4 | 6 | 2 | 1 | 1 | |||||
Liabilities And Stockhold… | |||||||||||||||
Liabilities And Stockhold… | |||||||||||||||
Liabilities Current | |||||||||||||||
Deferred Costs Current | - | - | - | - | - | - | - | - | 1 | - | |||||
Accounts Payable Current | - | - | 10 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | |||||
Accrued Liabilities Current | - | - | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |||||
Accounts Payable And Accrued Liabilities Current | 20 | 15 | - | - | - | - | - | - | - | - | |||||
Accrued Payroll Taxes Current | 0 | 0 | 0 | 0 | - | 0 | - | 0 | 0 | 0 | |||||
Dividends Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Notes Payable Current | - | 1 | - | - | - | - | - | - | - | 2 | |||||
Liabilities Current | 21 | 17 | 12 | 4 | 3 | 4 | 5 | 3 | 28 | 26 | |||||
Long Term Liabilities | |||||||||||||||
Liabilities Noncurrent | |||||||||||||||
Warrants And Rights Outstanding | - | - | - | - | - | 1 | 2 | - | - | - | |||||
Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 21 | 17 | 12 | 4 | 4 | 4 | 5 | 3 | 28 | 27 | |||||
Stockholders Deficit | |||||||||||||||
Temporary Equity | |||||||||||||||
Short Term Borrowings | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Temporary Equity Value Excluding Additional Paid I… | 1 | 1 | 1 | 1 | 2 | 5 | 4 | - | - | - | |||||
Temporary Equity Carrying Amount Attributable To P… | 1 | 1 | 1 | 1 | 2 | 5 | 4 | - | - | - | |||||
Stockholders Equity | |||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 74 | 67 | 61 | 57 | 52 | 38 | 35 | 35 | 5 | 5 | |||||
Retained Earnings Accumulated Deficit | -86 | -78 | -67 | -54 | -47 | -42 | -38 | -35 | -33 | -31 | |||||
Stockholders Equity | -12 | -11 | -6 | 4 | 5 | -4 | -3 | -1 | -27 | -26 | |||||
Liabilities And Stockholders Equity | 10 | 7 | 7 | 9 | 10 | 4 | 6 | 2 | 1 | 1 | |||||
Series A Preferred Stock | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | |||||
Temporary Equity Par Or Stated Value Per Share | 0.001 | 0.001 | - | - | - | - | - | - | - | - | |||||
Temporary Equity Shares Authorized | 3 | 3 | - | - | - | - | - | - | - | - | |||||
Temporary Equity Shares Issued | 0 | 0 | - | - | - | - | - | - | - | - | |||||
Temporary Equity Shares Outstanding | 0 | 0 | - | - | - | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 150 | 150 | 150 | 50 | 50 | 50 | 150 | 50 | 50 | 50 | |||||
Common Stock Shares Issued | 45 | 39 | 37 | 33 | 30 | 21 | 21 | 21 | 6 | 12 | |||||
Shares Outstanding | 45 | 39 | 37 | 33 | 30 | 21 | 21 | 21 | 6 | 12 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.73% | -2.89% | -7.51% | - | - | - | - | - | - | - | - | - |
| 2025 | 0.60% | 10.24% | 5.42% | 3.21% | -8.72% | -15.60% | 6.67% | -25.56% | -24.44% | 25.53% | 22.70% | 36.88% |
| 2024 | - | - | - | 32.28% | 3.80% | -16.77% | -14.55% | 93.64% | -16.36% | 3.90% | 9.09% | 15.58% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
OS Therapies Inc (OSTX) — SEC Financial Statements & Analysis
OS Therapies Inc (OSTX) is a pharmaceutical preparations company, incorporated in DE. OS Therapies Inc trades on NYSE as: OSTX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), OS Therapies Inc reported a Debt-to-Equity ratio of -1.74x, a Price-to-Book (P/B) ratio of -7.22x (TTM), at a market cap of $86.04M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -1.74x
- P/B TTM
- -7.22x
- Market Cap
- $86.04M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is OS Therapies Inc in?
OS Therapies Inc (OSTX) operates in the Pharmaceutical Preparations industry.
What is OSTX's market cap?
OS Therapies Inc (OSTX) has a market capitalization of $86.04M as of 2026-06-30.
What exchange does OSTX trade on?
OS Therapies Inc (OSTX) trades on the NYSE.
Where is OS Therapies Inc incorporated?
OS Therapies Inc is incorporated in DE.